NCT06344312View on ClinicalTrials.gov

Effectiveness of Yangxue Qingnao Granules in Preventing Post Thrombolytic Hemorrhage Transformation in Patients With Acute Cerebral Infarction

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

June 1, 2025

Conditions

Stroke, Acute Ischemic

Interventions

DRUG

Yangxue Qingnao Granules

When receiving intravenous thrombolysis with ateplase, two bags of Yangxue Qingnao Granule Simulator were randomly taken orally. Afterwards, one bag of Yangxue Qingnao Granule/ Simulator was taken three times a day for a total of two weeks.

Trial Locations (1)

Unknown

Peking University Third Hospital, Beijing

All Listed Sponsors

lead

Peking University Third Hospital

OTHER